Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 92696 · Class III · OneBlood Inc
Key facts
| Event ID | 92696 |
|---|---|
| Recall numbers | B-0555-2023, B-0556-2023, B-0557-2023, B-0558-2023 |
| Recalling firm | OneBlood Inc |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced, Liquid Plasma, Red Blood Cells, Leukocytes Reduced, Red Blood Cells, Leukocytes Reduced, Irradiated |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Blood products identified as unsuitable due to a storage deviation or unexpected event, were distributed. |
| Initiation date | Feb 15, 2023 |
| Report date | Jul 26, 2023 |
| Termination date | Jul 19, 2023 |
| City | Greensboro |
| State | NC |
| Country | United States |
| FEI number | 3011074190 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: